|Articles|May 1, 2007

Practice management in the era of anti-VEGF therapy (Part I)

Identifying the bottlenecks that are preventing effective management of neovascular AMD.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.


Latest CME